A peptide vial of Tirzepatide, manufactured by THELOBSTERLOVE, was analyzed by Janoshik Analytical to assess both content and purity. The batch tested, labeled LOB10, was submitted and paid for by TheLobster, the manufacturer.
Laboratory testing revealed a measured quantity of 10.98 mg, versus an assumed label claim of 10 mg, indicating a 9.8% overdose. This overfill is notable and, while not inherently dangerous, it reflects a potential inconsistency in production precision. Purity was reported at an exceptionally high 99.852%, indicating clean synthesis and absence of significant related compounds.
As the sample was manufacturer-submitted and manufacturer-funded, there remains a potential for selection bias—making it prudent to complement such data with independent consumer-funded testing where possible.
Detailed Report
Product Overview
- Manufacturer: THELOBSTERLOVE
- Product Name: THELOBSTER TIRZEPATIDE
- Active Ingredient: Tirzepatide
- Batch Number: LOB10
- Expiration Date: Not provided
- Delivery Method: Injectable peptide vial
Sample Acquisition and Testing
- Task Number: #58298
- Testing Ordered: 10 February 2025
- Sample Received: 20 February 2025
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: TheLobster (Manufacturer)
- Analysis Paid For By: TheLobster (Manufacturer)
Testing Results
| Component/Test | Specification (Label Claim) | Measured Concentration | Accuracy | Variance |
|---|---|---|---|---|
| Tirzepatide | 10 mg | 10.98 mg | 109.8% | +9.8% |
| Purity | N/A | 99.852% | — | — |
Verification Details
- Verification URL: https://janoshik.com/tests/58298_1C6LBZPHY5LQ
Evaluation of Manufacturer Testing
This sample displayed mild overdosing (9.8%), which, although likely beneficial to end users, also indicates deviation from strict dosing precision. The exceptionally high purity of 99.852% reflects high-quality production with minimal contaminants.
However, the results should be interpreted with consideration of potential selection bias, since the sample was provided directly by the manufacturer. Independent sampling by third parties would help corroborate these findings.
Conclusion
THELOBSTER’s Tirzepatide testing shows a 9.8% overdose and extremely high purity, making it a promising result in terms of peptide quality. However, the manufacturer-submitted nature of the sample requires careful interpretation. Third-party, anonymous testing remains the gold standard for confirming production integrity.
Disclaimer
This report is published for educational and harm reduction purposes only. Manufacturer-funded testing is helpful but should be verified through independently procured samples to ensure unbiased results. Always consider third-party verification when assessing product quality.
SEO Metadata
- SEO Title: THELOBSTER Tirzepatide Lab Test Results – February 2025
- URL Slug: thelobster-tirzepatide-lab-report-feb-2025
- Meta Description: Feb 2025 Janoshik lab test of THELOBSTER Tirzepatide shows 9.8% overfill and 99.85% purity. Manufacturer-funded analysis for batch LOB10.
